fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Developing a pharmacist-led outpatient pulmonary embolism pathway

Written by | 22 Jul 2024

Kieron Power is Principal Pharmacist for Thrombosis and Anticoagulation in Swansea Bay University Health Board in South Wales. He has played a leading role in the development of… read more.

How to establish a sustainable pulmonary embolism service

Written by | 21 Jul 2024

A number of features have contributed to the success of the pharmacy-led outpatient PE pathway including a close working relationship with the doctors, the systematic delivery of seven-day… read more.

What impact has the pulmonary embolism pathway had?

Written by | 20 Jul 2024

Evaluation of the new outpatient pulmonary embolism pathway showed that about 30% of patients could be managed safely and effectively via this route. Kieron Power, Principal Pharmacist for… read more.

How the pulmonary embolism pathway ensures consistent decision-making

Written by | 19 Jul 2024

The pulmonary embolism pathway has been designed to ensure acute risk assessment and appropriate follow up for all pulmonary embolism patients whether treated as inpatients or outpatients, according… read more.

How are high and low-risk pulmonary embolisms diagnosed and managed?

Written by | 18 Jul 2024

Improved diagnostic techniques mean that many more low-risk pulmonary embolisms are being diagnosed now. However, a recent national report identified numerous shortcomings in the management of pulmonary embolism… read more.

Pulmonary embolism – what patients experience

Written by | 17 Jul 2024

Kieron Power is Principal Pharmacist for Thrombosis and Anticoagulation in Swansea Bay University Health Board in South Wales. He has played a leading role in the development of… read more.

Early aspirin treatment shows promise in averting death in COVID-19

Written by | 1 Apr 2022

Early aspirin therapy appears to reduce mortality among patients with moderate COVID-19, researchers reported on March 24, 2022 in JAMA Network Open. “This is our third study and… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.